Corvia Medical Reports: Reduce Lap-HF II Analyses Show 50% of Study Patients Demonstrated Significant Clinical Benefit from the Corvia Atrial Shunt

Corvia Medical notes in a large responder population, representing 50% of study patients, treatment with the Corvia® Atrial Shunt resulted in a 45% reduction in HF events and a 55% greater improvement in quality of life compared to sham control.